Cerebral Vein Thrombosis and Lupus Anticoagulant Antibodies

Rosendaal FR Risk factors for venous thromboembolic disease . Thromb Haemost 1999;82:610.

Khamashta MA Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 1998 :7(Suppl 2):S162.

Khamashta MA , Cuadrado MJ , Mujic F. , et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993.

Greaves M. , Cohen H. , Machin SJ , et al. On behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000;109:704.

Couturaud F. , and Kearon C. Long-term treatment for venous thromboembolism . Curr Opin Hematol 2000;7:302.

de Brujin Sftm , Stam J. , for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484.

Ginsberg JS , Wells PS , Brill-Edwards P. , et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685.

Hyers TM , Agnelli G. , Hull RD , et al. Antithrombotic therapy for venous thromboembolic disease. Chest 1998;114:561S.

Kearon Cmb , Gent M. , Hirsh J. , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901.